Rising care costs According tothe CBO, the result of the proposal would be huge savings totaxpayers, and far-reaching effects in the pharmaceutical industry.(Photo: Shutterstock)

(Bloomberg) –A drug-price proposal from Democrats in Congresswould save taxpayers $345 billion over a seven-year period,according to a new estimate, punching a hole in pharmaceuticalcompany sales and causing ripple effects in health care systemsaround the world.

The bill, H.R. 3, is backed by Speaker of the House Nancy Pelosiand other Democrats in the chamber. It would direct Medicare, theU.S. government health program for the elderly and disabled, to setpharmaceutical prices based on an index of what other developednations pay for top-selling drugs. For products not sold abroad,the government would set their price at a discount to what U.S.purchasers paid.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.